Actemra 200mg, a treatment known scientifically as tocilizumab, is a a potent biologic agent primarily used for the management of rheumatoid arthritis. This remarkable agent operates by blocking the activity of interleukin-6 (IL-6), a regulatory protein crucial in the inflammatory process. Additionally, Actemra exhibits promise in the control of a